The relationship between obesity and the incidence of infertility in women

• Autorzy: Kryska S.
• Języki publikacji: EN

Abstrakty

EN

A significant increase in the incidence of obesity, which has taken place in recent years caused that began to talk about the epidemic of obesity. This problem is characteristic of highly developed countries. Increasingly, also occurs in developing countries, including Polish. It occurs in all age groups and in almost all social groups. The disease is currently diagnosed in almost 25% of the Polish population. Increasingly, it is also diagnosed in young women and pregnant women. The literature increasingly emphasized the importance of obesity in disorders of insemination and proper implantation the fertilized ovum. For women who are overweight and obese, more often than women with normal body weight, comes to ovulation disorders and disturbances in the proper implantation of the fertilized ovum. These disorders result from the accumulation of adipose tissue and hormonal disorders resulting from them. Influence on fertility of women have not only expressed as their body weight BMI, but also as the content in the body fat and its distribution. The higher the fat content in the body making it harder and longer may be infertility treatment. It also noted the relationship between fat distribution and duration of treatment of infertility and its effect. More and more often also emphasized the importance of incorrect diets in young women as a factor in reducing fertility. This article is an attempt to collect and characterize the major causes of infertility seen in young women who are overweight or obese.

Słowa kluczowe

EN

relationship; obesity; incidence; infertility; woman; overweight; young woman; body mass index; adipose tissue

• Wydawca: -
• Czasopismo: Health Problems of Civilization
• Rocznik: 2014
• Tom: 08
• Numer: 3
• Opis fizyczny: p.25-28,ref.

Twórcy

autor

Kryska S.

• Medical University of Silesia, Plac Traugutta 2, 41-800 Zabrze, Poland

Bibliografia

• 1. Badawy A., Elnashar A. (2011), Treatment options for polycystic ovary syndrome. Int. J. Womens Health; 3: 25–35.
• 2. Bebelska K.P., Ehmke vel Emczyńska E., Gmoch-Gajzlerska E. (2011), Otyłość jako czynnik zaburzający procesy rozrodcze, Nowiny Lekarskie; 80, 6, 499–507.
• 3. Berner-Trąbska M., Kowalska-Koprek U., Karowicz-Bilińska A. et al. (2009), Wpływ nadwagi lub otyłości u ciężarnych na przebieg ciąży i okresu okołoporodowego z uwzględnieniem stanu urodzeniowego noworodka w oparciu o materiał kliniczny. Ginekol. Pol., 80, 845-850.
• 4. Boivin J., Bunting L., Collins J.A. et al. (2007), International estimates of infertility prevalence and treatmentseeking: potential need and demand for infertility medical care. Hum. Reprod.; 22: 1506–1512.
• 5. Chavarro J.E., Rich-Edwards J.W., Rosner B.A. et al. (2007), Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet. Gynecol.; 110: 1050–1058.
• 6. Demissie M., Milewicz A. (2003), Zaburzenia hormonalne w otyłości. Diabetol. Prakt.; 3: 207–209.
• 7. Doak C.M. et al. (2012), Age standardization in mapping adult overweight and obesity trends in the WHO European Region. Obes Rev 13(2):174–191.
• 8. Fitzsimons K.J. Modder J. (2010), Setting maternity care standards for women with obesity in pregnancy. Semin. Fetal Neonatal Med., 15, 100-107.
• 9. Greer I.A., Walters B.N.J., Nelson-Piercy C. (2009), Otyłość. Wydawnictwo Elsevier Urban and Partner, Wrocław, 111-115.
• 10. Hajduk M. (2012), Wpływ masy ciała na płodność kobiet, Endokrynologia, Otyłość i Zaburzenia Przemiany Materii, tom 8, nr 3, s. 93-97.
• 11. Health and life style idicators in the European Union (2009), European Nutrition and Health Report 2009. Forum Nutr., Basel, Krager, 62, 157-201.
• 12. Hofny E.R.M., Ali M.E., Abdel-Hafez H.Z. et al. (2010), Semen parameters and hormonal profile in obese fertile and infertile males. Fertil. Steril., 94, 2, 581-584.
• 13. Iranmanesh A., Lizarralde G., Veldhuis J.D. (1991), Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endcocrinol. Metab.; 73: 1081–108.
• 14. James W.P. (2008), The epidemiology of obesity the size of the problem. J. Intern. Med. 263: 336–352.
• 15. Jarvie E., Ramsay J.E. (2010), Obstetric management of obesity in pregnancy. Semin. Fetal Neonatal Med., 15, 83-88.
• 16. Kanadys W.M., Leszczyńska-Gorzelak B. Mierzyński R. et al. (2002), Kliniczne aspekty otyłości w ciąży. Kliniczna Perinatologia i Ginekologia. Ośrodek Wydawnictw Naukowych, Poznań, 36, 145-151.
• 17. Kitabchi A.E., Temprosa M., Knowler W.C. et al. (2005), Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes; 54: 2404–2414.
• 18. Kłosiewicz-Latoszek R. (2010), Otyłość jako problem społeczny, zdrowotny i leczniczy. Probl. Hig., 91, 3, 339-343.
• 19. Moschos S., Chan J.L., Mantzoros C.S. (2002), Leptin and reproduction: a review. Fertil. Steril.; 77: 433–444.
• 20. Pupek-Musialik D., Kujawska-Łuczak M., Bogdański P. (2008), Otyłość i nadwaga – epidemia XXI wieku. Przew. Lek., 1, 117-123.
• 21. Rich-Edwards J.W., Spiegelman D., Garland M. (2002), Physical activity, body mass index, and ovulatory disorder infertility, Epidemiology; 13: 184–190.
• 22. Sarfati J., Young J., Christin-Maitre S. (2010), Obesity and female reproduction. Ann. Endocrinol.; 71: 49–53.
• 23. Wang Y., Beydoum M.A. (2007), The obesity epidemic in the United States – gender, age, socioeconomic racial/ ethnic and geographic characteristics: a systematic review and metaregression analysis. Epidemiol. Rev., 29, 6-28.
• 24. Wickiewicz D., Zimmer M. (2008), Otyłość a problem niepłodności u kobiet, Perinatologia, Neonatologia i Ginekologia, tom 1, zeszyt 2, 138-140.
• 25. Wieloośrodkowe Ogólnopolskie Badanie Stanu Zdrowia Ludności (2005), Program WOBASZ. Wydawnictwo Instytut Kardiologii, Warszawa, 90, 1-128.